Drug Use-result Survey to Assess the Safety and Efficacy of the Combination of Tacrolimus + Biological Agents in Daily Clinical Settings
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2016
At a glance
- Drugs Tacrolimus (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 31 Aug 2018 Biomarkers information updated
- 02 Oct 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 19 Sep 2015 Interim results (n= 175) published in the Drugs in R and D.